TABLE I.
Demographic, Clinical, and Urodynamic Data for the 11 Female Subjects
Mean | SD | Median | Range | #/11 | |
---|---|---|---|---|---|
Age (y) | 65.1 | 4.2 | 63 | 60–71 | |
MMSE (/30) | 29.0 | 1.9 | 30 | 24–30 | |
Independently mobile | 11/11 | ||||
Pregnancies, deliveries | 2/11, 2/11 | 0–4, 0–4 | |||
History of stress incontinence | 3/11 | ||||
Current anti-muscarinic or similar medication | 0/11 | ||||
Hysterectomy | 1/11 | ||||
| |||||
Comorbidities | Depression | 3/11 | |||
COPD | 1/11 | ||||
Vaginal atrophy | 1/11 | ||||
History of seizure | 1/11 | ||||
| |||||
First desire to void (ml) | 309 | 174 | 350 | 80–550 | |
Strong desire to void (ml) | 510 | 95 | 530 | 350–650 | |
PVR after free flow in private (ml) | 2.3 | 5.2 | 0 | 0–15 | |
Volume voided post-fMRI (ml) | 507 | 244 | 450 | 200–1,100 | |
Maximum cystometric capacity (ml) | 568 | 108 | 610 | 360–680 | |
Max voided volume on diary (ml) | 647 | 174 | 690 | 300–870 | |
Daytime voiding frequency on diary (#/24 hr) | 6.2 | 0.9 | 6.0 | 5.0–7.7 | |
Nocturia on diary (#) | 0.75 | 0.77 | 0.70 | 0–2.0 |